Softgel Manufacturing Equipment Market latest Statistics on Market Size, Growth, Production, Sales Volume, Sales Price, Market Share and Import vs Export 

Softgel Manufacturing Equipment Market Summary Highlights 

The Softgel Manufacturing Equipment Market is demonstrating sustained structural expansion, supported by pharmaceutical solid-dose innovation, nutraceutical consumption growth, and contract manufacturing capacity additions. Increasing demand for encapsulated lipid-based formulations, plant-based softgels, and high-bioavailability dosage formats is reshaping equipment design priorities. Automation, throughput optimization, and regulatory-grade validation capabilities are becoming standard purchasing criteria.

The Softgel Manufacturing Equipment Market Size is projected to reach approximately USD 820 million in 2025 and is forecast to surpass USD 1.18 billion by 2030, expanding at a CAGR of 7.6% during 2025–2030. Growth momentum is strongest in Asia-Pacific and North America, supported by pharmaceutical outsourcing and dietary supplement production scale-up. 

Statistical Snapshot – Softgel Manufacturing Equipment Market 

• The Softgel Manufacturing Equipment Market Size is estimated at USD 820 million in 2025.

• Projected CAGR (2025–2030): 7.6%. 

• Asia-Pacific accounts for ~38% of global revenue in 2025. 

• Pharmaceutical applications represent 54% of total equipment demand. 

• Nutraceutical and dietary supplements contribute 34% share. 

• Fully automated encapsulation lines account for 61% of new installations in 2025. 

• High-speed machines (>150,000 softgels/hour) represent 46% of total sales. 

• Contract manufacturing organizations (CMOs) generate 42% of total equipment purchases. 

• Plant-based/vegetarian capsule processing equipment demand is growing at 11.2% CAGR. 

• Retrofit and upgrade installations contribute nearly 28% of annual revenue in 2025. 

Increasing Pharmaceutical Encapsulation Demand Driving the Softgel Manufacturing Equipment Market 

Pharmaceutical pipeline diversification is a primary growth lever for the Softgel Manufacturing Equipment Market. Lipid-based drug delivery systems, poorly soluble APIs, and combination therapies are increasingly being commercialized in softgel format due to enhanced bioavailability and patient compliance.

For instance, approximately 42% of newly approved small-molecule drugs in 2025 exhibit low aqueous solubility, compared to 35% in 2020. This shift directly increases the need for advanced encapsulation systems capable of handling oil suspensions, semi-solid matrices, and micro-emulsions. As a result, pharmaceutical-grade softgel encapsulation machines with precision die-roll systems and automated fill-weight control are witnessing demand growth of 8.9% annually.

The Softgel Manufacturing Equipment Market benefits from rising oncology, cardiovascular, and CNS drug launches requiring modified-release softgel formats. Oncology drug encapsulation demand alone is expanding at 9.4% CAGR through 2030. Equipment manufacturers are integrating servo-controlled pump systems and in-line inspection modules to maintain ±1% fill-weight accuracy, meeting stricter validation requirements.

Capacity expansions further reinforce this trajectory. In 2025, global pharmaceutical production capacity for softgel formulations increased by nearly 6.8%, driven largely by outsourcing to CMOs in India, China, and the U.S. Each new production line requires encapsulation, drying tunnels, polishing units, and inspection systems—thereby expanding the Softgel Manufacturing Equipment Market ecosystem.

Nutraceutical Consumption Surge Accelerating the Softgel Manufacturing Equipment Market 

The nutraceutical sector remains a structural driver of the Softgel Manufacturing Equipment Market. Global dietary supplement consumption is projected to grow at 8.1% CAGR between 2025 and 2030, with omega-3, vitamin D, curcumin, CBD, and herbal extracts dominating softgel formats.

For example, omega-3 supplement demand is increasing at 7.5% annually in North America, while botanical extract supplements in Asia-Pacific are expanding at over 10% annually. Softgels are preferred for oil-based actives, accounting for nearly 63% of fish oil supplement formats in 2025.

This demand growth translates directly into equipment orders. Nutraceutical manufacturers are investing in mid-capacity encapsulation machines (60,000–100,000 softgels/hour), which represent 39% of new equipment purchases in 2025. The Softgel Manufacturing Equipment Market is seeing higher penetration of modular production lines tailored for multi-SKU production, allowing rapid changeovers and smaller batch flexibility.

Private label expansion is another catalyst. Nearly 31% of supplement sales in 2025 are private-label products, compared to 24% in 2021. Private-label manufacturers typically require scalable, cost-efficient encapsulation lines. Consequently, semi-automatic and compact automated systems are gaining traction, contributing approximately 22% of total revenue within the Softgel Manufacturing Equipment Market.

Automation and Industry 4.0 Integration Transforming the Softgel Manufacturing Equipment Market 

Automation intensity is increasing across the Softgel Manufacturing Equipment Market, driven by labor optimization, regulatory compliance, and operational consistency. Fully automated lines incorporating PLC-based control systems, real-time viscosity monitoring, and AI-assisted defect detection are becoming standard.

In 2025, around 61% of newly installed equipment lines are fully automated, compared to 48% in 2020. High-speed encapsulation systems capable of exceeding 180,000 softgels per hour are growing at 9.8% CAGR. Automation reduces material wastage by approximately 12–15% and improves batch consistency by 18%, directly impacting ROI.

For instance, AI-powered visual inspection modules reduce rejection rates from 3.2% to under 1.1%, improving production yield. This efficiency gain significantly influences procurement decisions within the Softgel Manufacturing Equipment Market.

Digital twin simulation tools are also being adopted to optimize die-roll calibration and gelatin ribbon thickness. Approximately 27% of Tier-1 pharmaceutical softgel facilities in 2025 are implementing predictive maintenance modules to reduce downtime by up to 22%.

Such technology-driven upgrades are pushing premium equipment segments to grow faster than conventional systems, reinforcing the value-based growth profile of the Softgel Manufacturing Equipment Market.

Expansion of Contract Manufacturing Strengthening the Softgel Manufacturing Equipment Market 

The rise of contract manufacturing organizations is a structural enabler of the Softgel Manufacturing Equipment Market. In 2025, CMOs account for 42% of global softgel production capacity, up from 36% in 2021.

Outsourcing penetration in pharmaceutical softgel production is projected to reach 48% by 2030. CMOs invest in high-throughput, multi-format encapsulation lines to serve diverse clients. This model increases equipment replacement cycles and demand for redundant production lines to ensure operational continuity.

Asia-Pacific leads in CMO-driven equipment procurement, representing 44% of global new equipment installations in 2025. India and China collectively account for nearly 28% of global CMO-based softgel capacity expansion.

The Softgel Manufacturing Equipment Market Size benefits from this outsourcing shift, as CMOs typically invest in scalable equipment platforms that support capsule size variation, vegetarian gelatin alternatives, and complex fill materials.

Moreover, CMOs prioritize regulatory-compliant systems with 21 CFR Part 11-ready documentation features. Equipment suppliers offering validation-ready documentation packages capture higher margins, contributing to premiumization within the Softgel Manufacturing Equipment Market.

Growing Demand for Plant-Based and Specialty Softgels Boosting the Softgel Manufacturing Equipment Market 

Consumer preference shifts toward vegetarian and clean-label formulations are reshaping the Softgel Manufacturing Equipment Market. Plant-based softgels made from starch or carrageenan-based shells are expanding at 11.2% CAGR between 2025 and 2030.

Traditional gelatin-based systems require adaptation when processing non-gelatin materials due to differences in viscosity and setting behavior. Equipment manufacturers are developing specialized ribbon formation systems and temperature-controlled drying tunnels to accommodate plant-derived materials.

In 2025, plant-based softgel production accounts for 19% of global softgel output, compared to 12% in 2020. Europe leads adoption at 26% share of regional output. Equipment designed for vegetarian encapsulation is witnessing 13% annual demand growth, outperforming conventional systems.

Specialty softgels, such as chewable softgels and dual-fill capsules, are further diversifying equipment requirements. Dual-fill production lines are projected to grow at 9.1% CAGR, supported by combination nutraceutical products.

This product innovation pipeline reinforces long-term structural demand within the Softgel Manufacturing Equipment Market, positioning advanced encapsulation technologies as critical enablers of formulation differentiation.

Asia-Pacific Leadership in Softgel Manufacturing Equipment Market 

Asia-Pacific dominates the Softgel Manufacturing Equipment Market, accounting for approximately 38% of global revenue in 2025. The region’s expansion is supported by pharmaceutical outsourcing, large-scale nutraceutical manufacturing, and cost-competitive production ecosystems.

For instance, India and China together represent nearly 28% of global softgel output capacity. Pharmaceutical production value in Asia-Pacific is expanding at 8.4% annually through 2030, while dietary supplement production is growing at 9.2% CAGR. This dual-sector growth directly stimulates capital expenditure in encapsulation lines, drying tunnels, and automated inspection modules within the Softgel Manufacturing Equipment Market.

China leads in mid-to-high speed encapsulation systems (>120,000 softgels/hour), contributing over 32% of regional equipment installations in 2025. India follows with strong demand from contract manufacturing organizations, where nearly 46% of new softgel lines are commissioned for export-focused production.

Southeast Asia, including Indonesia, Thailand, and Vietnam, is emerging as a secondary hub. Nutraceutical output in ASEAN countries is rising at 10.1% CAGR, increasing demand for modular encapsulation units. As a result, the Softgel Manufacturing Equipment Market in Southeast Asia is projected to grow at 9.3% CAGR through 2030, outperforming the global average.

North America Stability in Softgel Manufacturing Equipment Market 

North America represents approximately 29% of the Softgel Manufacturing Equipment Market in 2025. Demand is driven by high-value pharmaceutical formulations, specialty nutraceutical brands, and technological modernization initiatives.

The United States alone accounts for nearly 81% of regional demand. Pharmaceutical R&D spending in 2025 exceeds USD 240 billion, with a significant portion allocated to bioavailability enhancement technologies. Approximately 44% of lipid-based drug delivery products in the U.S. are commercialized in softgel format, increasing reliance on high-precision encapsulation machinery.

Automation adoption is particularly strong. Around 67% of newly installed systems in North America are fully automated lines integrated with digital monitoring platforms. This technological preference elevates average system value, positively impacting the Softgel Manufacturing Equipment Market Size in the region.

Canada contributes roughly 7% of North American demand, supported by natural health product manufacturing. Plant-based softgel output in Canada is expanding at 12% CAGR, driving specialized equipment procurement.

Europe Innovation Focus in Softgel Manufacturing Equipment Market 

Europe holds approximately 24% share of the Softgel Manufacturing Equipment Market in 2025. The region emphasizes innovation, regulatory compliance, and plant-based capsule technologies.

Germany, Italy, France, and the United Kingdom collectively account for nearly 70% of European equipment demand. For instance, Germany’s pharmaceutical manufacturing output is expanding at 6.9% annually, while nutraceutical exports are growing at 8.2%.

Vegetarian softgels represent 26% of total softgel production in Europe, compared to 19% globally. This higher penetration requires modified ribbon-forming systems and controlled humidity drying tunnels, creating a premium equipment segment within the Softgel Manufacturing Equipment Market.

Eastern Europe is also expanding as a cost-competitive manufacturing base. Poland and Hungary report pharmaceutical output growth exceeding 8% annually, leading to incremental demand for mid-capacity encapsulation systems.

Latin America and Middle East Growth in Softgel Manufacturing Equipment Market 

Latin America accounts for nearly 6% of the Softgel Manufacturing Equipment Market in 2025, while the Middle East & Africa contribute around 3%.

Brazil dominates Latin American demand, representing over 55% of regional equipment installations. Nutraceutical consumption in Brazil is increasing at 9.8% CAGR, particularly in omega-3 and herbal supplement categories. Mexico follows with pharmaceutical manufacturing growth of 7.2%, stimulating investment in encapsulation lines.

In the Middle East, Saudi Arabia and the UAE are expanding domestic pharmaceutical manufacturing capacity as part of industrial diversification strategies. Pharmaceutical production growth in the GCC region is projected at 8.5% CAGR through 2030, indirectly strengthening the Softgel Manufacturing Equipment Market.

Although smaller in share, these regions exhibit above-average growth rates, creating incremental opportunities for equipment suppliers. 

Softgel Manufacturing Equipment Market Segmentation Highlights 

The Softgel Manufacturing Equipment Market is segmented by equipment type, application, automation level, capacity, and end-user profile.

By Equipment Type 

• Encapsulation machines: 52% market share in 2025 

• Drying systems (tumble dryers, drying tunnels): 18% 

• Inspection and sorting systems: 14% 

• Mixing and gelatin preparation units: 10% 

• Ancillary equipment: 6% 

Encapsulation systems remain dominant due to higher unit value and replacement frequency within the Softgel Manufacturing Equipment Market.

By Application 

• Pharmaceuticals: 54% 

• Nutraceuticals: 34% 

• Cosmetics and specialty products: 12% 

Pharmaceutical demand grows at 7.9% CAGR, while nutraceutical equipment demand expands at 8.6% CAGR. 

By Automation Level 

• Fully automated: 61% 

• Semi-automatic: 27% 

• Manual/low automation: 12% 

By Capacity 

• High-speed (>150,000 softgels/hour): 46% 

• Medium-speed (60,000–150,000/hour): 39%

• Low-speed (<60,000/hour): 15%

This segmentation structure reinforces premiumization trends within the Softgel Manufacturing Equipment Market.

Production Trend in Softgel Manufacturing Equipment Market 

Global Softgel Manufacturing Equipment production is increasing steadily to meet expanding pharmaceutical and nutraceutical demand. In 2025, total Softgel Manufacturing Equipment production is estimated at approximately 2,850 units globally, compared to 2,420 units in 2022. Annual Softgel Manufacturing Equipment production capacity is expanding at 5.8% CAGR through 2030.

Asia-Pacific accounts for nearly 41% of total Softgel Manufacturing Equipment production, followed by Europe at 27% and North America at 23%. Domestic Softgel Manufacturing Equipment production in China has grown by 9.1% annually, reflecting strong internal demand and export capability. Meanwhile, specialized high-precision Softgel Manufacturing Equipment production in Germany and the United States focuses on premium automated lines with higher average selling prices. 

Softgel Manufacturing Equipment Price Dynamics in Softgel Manufacturing Equipment Market 

The Softgel Manufacturing Equipment Price varies significantly based on capacity, automation level, and compliance specifications. In 2025:

• Low-capacity semi-automatic systems range between USD 120,000–250,000. 

• Mid-capacity automated systems range between USD 400,000–750,000. 

• High-speed fully automated lines exceed USD 1.2–2.5 million. 

The average Softgel Manufacturing Equipment Price increased by approximately 4.6% year-over-year in 2025 due to rising stainless steel costs, servo-motor integration, and advanced inspection modules.

The Softgel Manufacturing Equipment Price Trend indicates moderate upward movement between 2025 and 2027, with annual increases projected at 3.5–4.2%. For instance, integration of AI-driven visual inspection increases total system cost by nearly 8–12%, but improves yield efficiency by up to 18%, justifying higher procurement budgets.

Currency fluctuations also influence the Softgel Manufacturing Equipment Price Trend, particularly for cross-border purchases between Asia and North America. European-manufactured high-end systems command 15–20% premium over comparable Asian systems, reflecting regulatory validation packages and engineering precision.

Bulk procurement by CMOs often results in negotiated discounts of 6–9%, slightly moderating the overall Softgel Manufacturing Equipment Price Trend in high-volume markets.

Between 2026 and 2030, the Softgel Manufacturing Equipment Price Trend is expected to stabilize as component supply chains normalize. However, premium smart manufacturing systems will continue to command higher pricing tiers, keeping the blended Softgel Manufacturing Equipment Price on a gradual upward trajectory. 

Leading Players in Softgel Manufacturing Equipment Market 

The competitive landscape of the Softgel Manufacturing Equipment Market in 2025 reflects moderate consolidation at the top and strong fragmentation across regional manufacturers. Market share distribution is influenced by automation capability, production throughput, compliance documentation support, vegetarian capsule compatibility, and global service networks.

Tier-1 suppliers collectively account for approximately 48–52% of total revenue in the Softgel Manufacturing Equipment Market, while mid-tier and regional manufacturers contribute the remaining 48–52%, largely driven by price-sensitive installations in Asia-Pacific and Latin America.

Below is a structured assessment of leading manufacturers and their estimated 2025 market share ranges. 

Technophar – Premium Segment Leader in Softgel Manufacturing Equipment Market 

Estimated 2025 market share: 12–14%

Technophar remains one of the most established names in the Softgel Manufacturing Equipment Market, particularly in high-capacity pharmaceutical and nutraceutical encapsulation systems. Its TES Series and TES VGen encapsulation machines are widely deployed in facilities producing both gelatin and vegetarian softgels.

The TES VGen platform is optimized for plant-based shell materials and includes servo-driven fill pumps, advanced die-roll control, and integrated tumble drying solutions. These features align with rising demand for vegetarian softgels, which are growing at over 11% CAGR globally.

Technophar’s competitive positioning is strengthened by turnkey line integration capabilities, including gelatin preparation tanks, drying tunnels, and in-line inspection systems. Its equipment is particularly prevalent in North America and Europe, where validation-ready documentation and GMP compliance drive procurement decisions. 

ACIC / Pharmagel – High-Speed Pharmaceutical Focus in Softgel Manufacturing Equipment Market 

Estimated 2025 market share: 9–11%

ACIC, through its Pharmagel encapsulation systems, commands strong presence in pharmaceutical-grade equipment installations within the Softgel Manufacturing Equipment Market. The GK and HT Series encapsulation machines are designed for high-speed production exceeding 150,000 softgels per hour.

These systems emphasize:

• Precision fill-weight control (±1% tolerance) 

• Automated ribbon thickness monitoring 

• PLC-based digital control interfaces 

• Regulatory-compliant documentation systems 

Pharmaceutical softgel production accounts for 54% of total market demand in 2025, directly benefiting suppliers like ACIC that focus on high-validation environments. Its installed base is concentrated in North America and expanding across Asia-Pacific CMOs. 

CapPlus Technologies / Captek – Turnkey Solutions in Softgel Manufacturing Equipment Market 

Estimated 2025 market share: 7–9%

CapPlus and Captek Solutions focus on turnkey mid-capacity production lines within the Softgel Manufacturing Equipment Market, serving nutraceutical brands and contract manufacturers.

Its CPT T-Series encapsulation systems cater to production ranges between 60,000 and 120,000 softgels per hour. These lines are often integrated with: 

• Tumble dryers 

• Capsule polishers 

• Sorting and inspection units 

• Oil filling modules 

The company benefits from private-label supplement expansion, which represents 31% of global supplement sales in 2025. Mid-scale producers prefer modular systems that allow SKU flexibility, reinforcing CapPlus’ steady market share. 

ChangSung – Rotary System Specialist in Softgel Manufacturing Equipment Market 

Estimated 2025 market share: 6–8%

ChangSung remains a recognized rotary die encapsulation machine supplier within the Softgel Manufacturing Equipment Market. Models such as the 380SRP and 780SR series are widely deployed in Asia-Pacific and distributed internationally.

ChangSung equipment is known for: 

• Robust rotary die technology 

• Multi-cavity die options 

• Adaptability for oil-based and suspension fills 

• Competitive pricing relative to European systems 

Its strength lies in balancing performance and cost, making it particularly attractive to emerging-market manufacturers expanding nutraceutical production capacity at 9–10% annual growth rates. 

Geltec and Seamless Technology Providers in Softgel Manufacturing Equipment Market 

Estimated 2025 combined market share: 5–7%

Seamless softgel manufacturers represent a niche but growing segment of the Softgel Manufacturing Equipment Market. These systems produce spherical capsules without die seams using jet-droplet or gravity-based encapsulation techniques. 

Seamless systems are increasingly used in: 

• Cosmetic capsules 

• Functional beverages 

• Specialty nutraceutical applications 

Seamless softgel production demand is expanding at approximately 9.1% CAGR, contributing incremental share to this specialized equipment category. 

Chinese OEM Cluster – Volume Leaders in Softgel Manufacturing Equipment Market 

Estimated 2025 collective market share: 18–22%

Chinese manufacturers collectively represent the largest unit-volume suppliers within the Softgel Manufacturing Equipment Market, though average selling prices are lower compared to European or North American systems.

These suppliers focus on: 

• Entry-level rotary encapsulators 

• Mid-speed machines (60,000–100,000 softgels/hour) 

• Integrated drying tunnels 

• Cost-efficient turnkey lines 

Asia-Pacific accounts for 38% of total global demand in 2025, and regional sourcing preferences support strong domestic OEM growth. Price competitiveness remains their primary differentiator. 

Softgel Manufacturing Equipment Market Share Structure 

The Softgel Manufacturing Equipment Market in 2025 demonstrates a multi-tier competitive hierarchy:

• Top 3 manufacturers: ~30–34% combined share 

• Top 5 manufacturers: ~40–45% combined share 

• Regional and emerging OEMs: ~55–60% collectively 

Market share is influenced by: 

• Automation intensity 

• Ability to process vegetarian capsules 

• High-speed encapsulation capability 

• Aftermarket service contracts 

• Validation and compliance documentation 

Premium suppliers capture higher revenue share due to automation-heavy systems priced between USD 1.2–2.5 million per line, whereas mid-tier OEMs compete in the USD 400,000–800,000 range. 

Competitive Positioning in Softgel Manufacturing Equipment Market 

Competition within the Softgel Manufacturing Equipment Market is increasingly centered on:

• High-throughput capability (>180,000 softgels/hour) 

• AI-powered defect detection 

• Multi-layer and dual-fill encapsulation compatibility 

• Vegetarian ribbon technology 

• Energy-efficient drying systems 

Automation penetration reached 61% of new installations in 2025, favoring suppliers offering Industry 4.0 integration. Predictive maintenance modules and remote diagnostics are becoming competitive necessities.

Aftermarket service contracts now account for approximately 12–15% of total supplier revenue, improving recurring income streams and strengthening customer retention within the Softgel Manufacturing Equipment Market.

Recent Developments and Industry Updates in Softgel Manufacturing Equipment Market 

Q1 2025 – Multiple Tier-1 manufacturers expanded production facilities in Asia-Pacific to meet rising CMO demand. Capacity expansions of 8–10% were reported across major equipment suppliers. 

Q2 2025 – Launch of upgraded vegetarian-compatible encapsulation modules capable of handling carrageenan-based shells, responding to 11% CAGR growth in plant-based softgels. 

Q3 2025 – Increased investment in AI-enabled visual inspection systems, reducing defect rates from 3% to below 1.2% in commercial lines. 

Q4 2025 (anticipated) – Integration of digital twin simulation software in premium encapsulation lines to reduce changeover time by 15–18%. 

2026 Outlook – Consolidation activity expected among mid-tier OEMs as automation investment requirements increase capital intensity.